Management of HIV in the pregnant woman

Clinical Obstetrics and Gynecology

Volumn 55, Issue 2, 2012, Pages 531-540

  Davis, John A ^a   Yawetz, Sigal ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

AIDS; antiretroviral therapy; ART; HIV; mother to child transmission; MTCT; pregnancy

Indexed keywords

ABACAVIR; ATAZANAVIR; DARUNAVIR; DIDANOSINE; EFAVIRENZ; ELVITEGRAVIR; EMTRICITABINE; ENFUVIRTIDE; ETRAVIRINE; FOSAMPRENAVIR; INDINAVIR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; MARAVIROC; NELFINAVIR; NEVIRAPINE; RALTEGRAVIR; RILPIVIRINE; RITONAVIR; SAQUINAVIR; STAVUDINE; TENOFOVIR; TENOFOVIR DISOPROXIL; TIPRANAVIR; ZIDOVUDINE;

ARTICLE; CYTOPENIA; DELIVERY; DIARRHEA; FEMALE; HEPATITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; IMMUNIZATION; INTRAPARTUM CARE; LACTIC ACIDOSIS; MATERNAL CARE; MOTHER CHILD RELATION; PANCREATITIS; PREGNANCY; PREGNANT WOMAN; PUERPERIUM; RASH; SCREENING TEST; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; CESAREAN SECTION; FEMALE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LABOR, OBSTETRIC; POSTNATAL CARE; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VIRAL LOAD;

EID: 84860295655     PISSN: 00099201     EISSN: 15325520     Source Type: Journal    
DOI: 10.1097/GRF.0b013e31824f3ae1     Document Type: Article

References (36)

1. Gottlieb MS, Schanker HM, Fan PT, et al. Pneumocystis pneumonia-Los Angeles. MMWR. 1981;30:1-3.
2. Joncas JH, Delage G, Chad Z, et al. Acquired (or congenital) immunodeficiency syndrome in infants born of Haitian mothers. N Engl J Med. 1983; 308:842.
3. World Health Organization. Global summary of the AIDS epidemic: 2009. Available at: Http://www.who.int/hiv/data/2009-global-summary.png. Accessed 11 September 2011.
4. World Health Organization. Towards universal access: Scaling up priority HIV/AIDS interventions in the health sector. Progress Rep. 2010;97.
5. Centers for Disease Control and Prevention. Pediatric HIV Surveillance (through 2009). Powerpoint slide set. Available at: Http://www.cdc.gov/hiv/ topics/surveillance/resources/slides/pediatric/index.htm. Accessed 11 September 2011.
6. Jones TB. Psychosocial dimensions of HIV infection in pregnancy. Clin Obstet Gynecol. 2008;51:456-466. (Pubitemid 351655115)
7. Clark J, Lampe MA, Jamieson DJ. Testing women for human immunodeficiency virus infection: Who, when, and how? Clin Obstet Gynecol. 51: 507-517.
8. Guidozzi F, Black V. The obstetric face and challenge of HIV/AIDS. Clin Obstet Gynecol. 2009;52:270-284.
9. Department of Health and Human Services, Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendation for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. September 14, 2011; pp 1-207. Available at: Http://aidsinfo.nih.gov/ContentFiles/PerinatalGL.pdf. Accessed 20 September 2011.
10. Riley LE, Yawetz S. Case records of the Massachusetts General Hospital: Case 32-2005. A 34-year-old HIV-positive women who desired to become pregnant. New Engl J Med. 2005;353:1725-1732.
11. Anderson BL, Cu-Uvin S. Pregnancy and optimal care of HIV-infected patients. Clin Inf Dis. 2009;48:449-455.
12. Mnyani CN, McIntyre JA. Preventing mother-T o-child transmission of HIV. BJOG. 2009;116 (suppl 1):71-76.
13. Reshi P, Lone IM. Human immunodeficiency virus and pregnancy. Arch Gynecol Obstet. 2010;281:781-792.
14. Mepham SO, Bland RM, Newell M-L. Prevention of mother-T o-child transmission of HIV in resource-rich and -poor settings. BJOG. 2011;118:202-218.
15. Centers for Disease Control and Prevention. HIV prevalence estimates-United States, 2006.MMWR. 2008;57:1073-1076.
16. Centers for Disease Control and Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR. 2006;55 (RR14):1-17.
17. National HIV/AIDS Clinicians' Consultation Center. 2011Compendium of State HIV Testing Laws. Available at: Http://www.nccc.ucsf.edu/consultation- library/state-hiv-T esting-laws/. Accessed September 11, 2011.
18. Garcia PM, Kalish LA, Pitt J, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. N Engl J Med. 1999;341:394-402. (Pubitemid 29362512)
19. European Collaborative Study. HIVinfected pregnant women and vertical transmission in Europe since 1986. AIDS. 2001;15:761-770.
20. Mwapassa V, Rogerson SJ, Kwiek JJ, et al. Maternal syphilis infection is associated with increased risk of motherto-child transmission of HIV in Malawi. AIDS. 2006;20:1869-1877. (Pubitemid 44358905)
21. Rodriguez EM, Mofenson LM, Chang BH, et al. Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission. AIDS. 1996;10:273-282. (Pubitemid 26093487)
22. Department of Health and Human Services, Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. October 14, 2011;1-166. Available at: Http://www.aids info.nih.gov/ContentFiles/AdultsandAdo lescentGL.pdf. Accessed October 31, 2011.
23. Heidari S, Mofenson L, Cotton MF, et al. Antiretroviral drugs for preventing mother-T o-child transmission of HIV: A review of potential effects on HIV-exposed but uninfected children. J Acquir Immune Defic Syndr. 2011;57:290-296.
24. Townsend CL, Cortina-Borja M, Peckham CS, et al. Low rates of motherto-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS. 2008;22:973-981. (Pubitemid 351652248)
25. Tubiana R, Le Chenadec J, Rouzioux C, et al. Factors associated with motherto-child transmission of HIV-1 despite a maternal viral load<500 copies/ml at delivery: A case-control study nested in theFrench perinatal cohort (EPF-ANRS CO1) Clin. Infect Dis. 2010 50 585-596
26. Siegfried N, van der Merwe L, Brocklehurst P, et al. Antiretrovirals for reducing the risk of mother-T o-child transmission of HIV infection. Cochrane Database Syst Rev. 2011;7:1-122.
27. Tuomala RE, Kalish LA, Zorilla C, et al. Changes in total CD4+, and CD8+ lymphocytes during pregnancy and 1 year postpartum in human immunodeficiency virus-infected women. Obstet Gynecol. 1997;89:967-974. (Pubitemid 27220464)
28. The International Perinatal HIV Group-T he mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1-a meta-analysis of 15 prospective cohort studies. N Engl J Med. 1999;340:977-987.
29. European Mode of Delivery Collaboration. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: A randomised clinical trial. The European mode of delivery collaboration. Lancet. 1999;353:1035-1039.
30. Louis J, Landon MB,GersnoviezRJ, et al. Perioperative morbidity and mortality among human immunodeficiency virus infected women undergoing cesarean delivery. Obstet Gynecol. 2007;110:385-390. (Pubitemid 47356665)
31. American College of Obstetricians and Gynecologists. ACOG committee opinion scheduled Cesarean delivery and the prevention of vertical transmission of HIV infection. Number 234, 2000 (replaces number 219, 1999). Int J Gynaecol Obstet. 2001;73:279-281.
32. Kind C, Rudin C, Claire-Anne S, et al. Prevention of vertical HIV transmission: Additive protective effect of elective cesarean section and zidovudine prophylaxis. AIDS. 1998;12:205-210. (Pubitemid 28035162)
33. Connor EM, Sperling RS, GelberR, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 1994;331:1173-1180. (Pubitemid 24331334)
34. Department of Health and Human Services, Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. August 11, 2011; pp. 1-268. Available at: Http://aidsinfo.nih.gov/ContentFiles/PediatricGuidelines.pdf. Accessed September 11, 2011.
35. Mirochnick M, Thomas T, Capparelli E, et al. Antiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapy. Antimicrob Agents Chemother. 2009;53: 1170-1176.
36. Lidstrom J, KumwendaN, KafulafulaG, et al. Antiretroviral treatment of HIV-infected women can induce multi-class drug resistance in their breastfeeding infants. Antiviral Ther. 2009;14 (suppl 1):A158.